<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Investig</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Investig</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)2040-1124</journal-id><journal-id journal-id-type="publisher-id">JDI</journal-id><journal-title-group><journal-title>Journal of Diabetes Investigation</journal-title></journal-title-group><issn pub-type="ppub">2040-1116</issn><issn pub-type="epub">2040-1124</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27181567</article-id><article-id pub-id-type="pmc">5009131</article-id><article-id pub-id-type="doi">10.1111/jdi.12498</article-id><article-id pub-id-type="publisher-id">JDI12498</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Articles</subject><subj-group subj-group-type="heading"><subject>Clinical Science and Care</subject></subj-group></subj-group></article-categories><title-group><article-title>Ideal glycated hemoglobin cut&#x02010;off points for screening diabetes and prediabetes in a Chinese population</article-title><alt-title alt-title-type="left-running-head">Liu <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="jdi12498-cr-0001" contrib-type="author"><name><surname>Liu</surname><given-names>Yujia</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0002" contrib-type="author"><name><surname>Xiao</surname><given-names>Xianchao</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0003" contrib-type="author"><name><surname>Sun</surname><given-names>Chenglin</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0004" contrib-type="author"><name><surname>Tian</surname><given-names>Suyan</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jdi12498-cr-0005" contrib-type="author"><name><surname>Sun</surname><given-names>Zhonghua</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0006" contrib-type="author"><name><surname>Gao</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0007" contrib-type="author"><name><surname>Li</surname><given-names>Yazhen</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0008" contrib-type="author"><name><surname>Cheng</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0009" contrib-type="author"><name><surname>Lv</surname><given-names>You</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0010" contrib-type="author"><name><surname>Li</surname><given-names>Mei</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0011" contrib-type="author"><name><surname>Li</surname><given-names>Zhuo</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0012" contrib-type="author"><name><surname>Zhang</surname><given-names>Yumin</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0013" contrib-type="author"><name><surname>Wang</surname><given-names>Gang</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0014" contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0015" contrib-type="author"><name><surname>Gao</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0016" contrib-type="author"><name><surname>Zhu</surname><given-names>Liwen</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0017" contrib-type="author"><name><surname>Liu</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jdi12498-cr-0018" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Guixia</given-names></name><xref ref-type="aff" rid="jdi12498-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jdi12498-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Endocrinology and Metabolism</named-content><institution>The First Hospital of Jilin University</institution><named-content content-type="city">Changchun</named-content><country>China</country></aff><aff id="jdi12498-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Epidemiology</named-content><institution>The First Hospital of Jilin University</institution><named-content content-type="city">Changchun</named-content><country country="CN">China</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Guixia Wang<break/>
Tel.: +86&#x02010;0431&#x02010;88782866<break/>
Fax: +86&#x02010;0431&#x02010;88786066<break/>
E&#x02010;mail address: <email>gwang168@jlu.edu.cn</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>03</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="ppub"><month>9</month><year>2016</year></pub-date><volume>7</volume><issue>5</issue><issue-id pub-id-type="doi">10.1111/jdi.2016.7.issue-5</issue-id><fpage>695</fpage><lpage>702</lpage><history><date date-type="received"><day>12</day><month>8</month><year>2015</year></date><date date-type="rev-recd"><day>25</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>09</day><month>2</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 Asian Association for the Study of Diabetes and John Wiley & Sons Australia, Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley &#x00026; Sons Australia, Ltd</copyright-statement><license license-type="creativeCommonsBy-nc"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution&#x02010;NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JDI-7-695.pdf"/><abstract id="jdi12498-abs-0001"><title>Abstract</title><sec id="jdi12498-sec-0001"><title>Aims/Introduction</title><p>The aims of the present study were to evaluate the diagnostic value of fasting plasma glucose, 2&#x02010;h postload plasma glucose and glycosylated hemoglobin (HbA1c) measurements in the screening of diabetes and prediabetes, and to determine the cut&#x02010;off point of HbA1c in the diagnosis of diabetes and prediabetes in a Chinese population.</p></sec><sec id="jdi12498-sec-0002"><title>Materials and Methods</title><p>A total of 7,611 individuals aged 40 years or older, who did not have a prior history of diabetes, were randomly selected in the Changchun area. For each participant, a questionnaire was completed, and a physical examination and an oral glucose tolerance test were carried out. The values of fasting plasma glucose, 2&#x02010;h postload plasma glucose and HbA1c were compared by area under the receiver operating characteristic curves. The Youden index was used to identify the optimal cut&#x02010;off point of HbA1c in the diagnosis of diabetes and prediabetes.</p></sec><sec id="jdi12498-sec-0003"><title>Results</title><p>The prevalence of newly diagnosed diabetes and prediabetes was 12.71% and 29.39%, respectively. In participants with newly diagnosed diabetes, the area under the receiver operating characteristic curve was 0.8368 for fasting plasma glucose, 0.9330 for 2&#x02010;h postload plasma glucose and 0.8064 for HbA1c; whereas for prediabetes, these values were 0.8022, 0.9288 and 0.6895, respectively. In addition, an HbA1c threshold of 6.3% showed the highest Youden index (0.4799) for detecting diabetes; furthermore, an HbA1c threshold of 5.8% showed the highest Youden index (0.2866) for detecting prediabetes.</p></sec><sec id="jdi12498-sec-0004"><title>Conclusions</title><p>HbA1c &#x02265;6.3% (45 mmol/mol) and between 5.8% and 6.2% (40&#x02013;44 mmol/mol) were the optimal cut&#x02010;off values for the diagnosis of diabetes and prediabetes, respectively, in a Chinese population.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jdi12498-kwd-0001">Chinese adults</kwd><kwd id="jdi12498-kwd-0002">Receiver operating characteristic curves</kwd><kwd id="jdi12498-kwd-0003">Type 2 diabetes mellitus</kwd></kwd-group><counts><page-count count="8"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jdi12498</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>September 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.4 mode:remove_FC converted:01.09.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jdi12498-cit-1001">
<source>J Diabetes Investig</source>
<year>2016</year>; <volume>7</volume>: <fpage>695</fpage>&#x02013;<lpage>702</lpage>
</mixed-citation>
</p></notes></front><body><sec id="jdi12498-sec-0005"><title>Introduction</title><p>In recent years, diabetes has become a serious public health threat worldwide, leading to increased all&#x02010;cause mortality, cardiovascular events such as revascularization, chest pain, heart attack, heart failure, stroke and even death in high&#x02010;risk patients<xref rid="jdi12498-bib-0001" ref-type="ref">1</xref>, <xref rid="jdi12498-bib-0002" ref-type="ref">2</xref>, <xref rid="jdi12498-bib-0003" ref-type="ref">3</xref>. With China's fast economic development, social urbanization, an increased aging population and a major shift towards a Western lifestyle, the prevalence of diabetes has increased dramatically. In 2008, the number of Chinese people who suffered from diabetes mellitus was 92.4 million<xref rid="jdi12498-bib-0004" ref-type="ref">4</xref>; and in 2013, the number of diabetic patients increased to 98 million according to the International Diabetes Federation report<xref rid="jdi12498-bib-0005" ref-type="ref">5</xref>. Diabetes complications, such as diabetic neuropathy, nephropathy and retinopathy, greatly reduce a patient's quality of life. Prediabetes (intermediate hyperglycemia) is a high&#x02010;risk state for diabetes when blood glucose levels are higher than normal, but lower than diabetes thresholds. Each year, 5&#x02013;10% of people with prediabetes will develop diabetes<xref rid="jdi12498-bib-0006" ref-type="ref">6</xref>. Therefore, early detection of diabetes and prediabetes with proper interventions will reduce the risk of diabetic complications and mortality<xref rid="jdi12498-bib-0007" ref-type="ref">7</xref>, <xref rid="jdi12498-bib-0008" ref-type="ref">8</xref>, <xref rid="jdi12498-bib-0009" ref-type="ref">9</xref>.</p><p>Fasting plasma glucose (FPG), 2&#x02010;h postload plasma glucose (2 h&#x02010;PPG), and glycosylated hemoglobin (HbA1c) determination are common methods for screening and diagnosing diabetes. Since 1999, the World Health Organization (WHO) has recommended FPG and 2 h&#x02010;PPG measurements as gold standards for the diagnosis of diabetes and prediabetes<xref rid="jdi12498-bib-0010" ref-type="ref">10</xref>. Later, the American Diabetes Association (ADA) and WHO also recommended the HbA1c measurement as a diagnostic method for diabetes<xref rid="jdi12498-bib-0011" ref-type="ref">11</xref>, <xref rid="jdi12498-bib-0012" ref-type="ref">12</xref>. Most previous studies have focused on the evaluation of FPG and HbA1c, mainly because of the lack of a large sample size to study 2 h&#x02010;PPG. However, as a predictive factor of chronic complications of type 2 diabetes mellitus, the 2 h&#x02010;PPG measurements have attracted increasing attention in recent years<xref rid="jdi12498-bib-0013" ref-type="ref">13</xref>, <xref rid="jdi12498-bib-0014" ref-type="ref">14</xref>.</p><p>The HbA1c level is not affected by diet, infection or stress; therefore, it can be used as a predictor of chronic complications of diabetes. However, so far, China has not yet established the HbA1c measurement as a diagnostic method for diabetes and prediabetes, mainly because of inadequate standardization of the HbA1c measurement and the lack of enough data to determine the cut&#x02010;off point for HbA1c<xref rid="jdi12498-bib-0015" ref-type="ref">15</xref>. A previous study in Singapore has shown that HbA1c values present significant differences among ethnic groups. For example, under the same conditions, the HbA1c level in Chinese is lower than that in Indians and Malays<xref rid="jdi12498-bib-0016" ref-type="ref">16</xref>. Another study also has shown that HbA1c &#x02265;6.5% has a low sensitivity for newly diagnosed diabetes<xref rid="jdi12498-bib-0017" ref-type="ref">17</xref>. Meanwhile, there are few studies on the HbA1c diagnostic threshold for prediabetes. Thus, it is critical to establish an appropriate HbA1c diagnostic cut&#x02010;off for diabetes and prediabetes in the Chinese population using a large sample size.</p><p>In the present study, we compared the sensitivity of FPG and 2 h&#x02010;PPG measurements in screening diabetes and prediabetes, and also compared the sensitivity and specificity of HbA1c with those of FPG and 2 h&#x02010;PPG measurements. In addition, the optimal cut&#x02010;off of the HbA1c test was explored for diagnosing diabetes and prediabetes in a population from Changchun, China.</p></sec><sec id="jdi12498-sec-0006"><title>Materials and Methods</title><sec id="jdi12498-sec-0007"><title>Study participants</title><p>The present work was one part of the baseline survey from the Risk Evaluation of Cancers in Chinese Diabetic Individuals: A Longitudinal Study investigating the association between diabetes and cancer, which was carried out among 259,657 adults, aged years or older from 25 communities across mainland China, from 2011 to 2012<xref rid="jdi12498-bib-0018" ref-type="ref">18</xref>, <xref rid="jdi12498-bib-0019" ref-type="ref">19</xref>, <xref rid="jdi12498-bib-0020" ref-type="ref">20</xref>. A total of 10,175 people were randomly selected from six communities in Changchun, China. They were invited to participate in the present study according to the following criteria: aged 40 years or older; had lived in their current residence for 5 years or longer; and could move freely. The exclusion criteria were as follows: those who were ever diagnosed previously with diabetes; those who had suffered from cardiovascular events, stroke, infection, trauma or surgery in the past 3 months; and those who had a history of anemia or use of glucocorticoids. A total of 9,571 participants (3,161 men and 6,410 women) completed the study. After the exclusion of 1,509 subjects, who had a previous history of diabetes, and 451 subjects, for whom data on fasting, 2&#x02010;h plasma glucose levels or HbA1c were missing, 7,611 adults (2,435 men and 5,176 women) were included in the final analysis for the present study.</p></sec><sec id="jdi12498-sec-0008"><title>Ethics Statement</title><p>The Ruijin Hospital Ethics Committee of Shanghai Jiao Tong University School of Medicine approved the study protocol. Written informed consent was obtained from each participant before data collection.</p></sec><sec id="jdi12498-sec-0009"><title>Study design and laboratory testing</title><p>Each participant received a physical examination including measurements of height, weight, waist circumference, hip circumference and blood pressure, and completed a questionnaire including basic personal information, and history of diabetes and family diseases. After an overnight fast of 8&#x02013;14 h, a venous blood sample was collected to measure the levels of FPG, triglycerides, total cholesterol, low&#x02010;density lipoprotein cholesterol and high&#x02010;density lipoprotein cholesterol. In addition, a fingertip blood sample was collected, prepared, stored and transported as per the standard protocol using the Hemoglobin Capillary Collection System (Bio&#x02010;Rad Laboratories, Hercules, CA, USA) for measurement of HbA1c. Next, each participant was given a standard 75&#x02010;g glucose solution orally for the glucose tolerance test. To measure 2 h&#x02010;PPG, blood samples were collected 2 h after the glucose load.</p><p>Plasma glucose concentrations were measured by the glucose oxidase method (Bayer ADVIA2400, Leverkusen, Germany)<xref rid="jdi12498-bib-0021" ref-type="ref">21</xref> in collaboration with the Central Laboratory of the First Hospital of Jilin University. The measurements of triglycerides, total cholesterol, low&#x02010;density lipoprotein cholesterol and high&#x02010;density lipoprotein cholesterol were carried out using an enzymatic colorimetric method (LX&#x02010;20; Beckman, Brea, CA, USA) by the Shanghai Institute of Endocrinology and Metabolism; and the measurement of HbA1c was carried out by a high&#x02010;performance liquid chromatography method (Bio&#x02010;Rad Laboratories, Hercules, CA, USA)<xref rid="jdi12498-bib-0022" ref-type="ref">22</xref>.</p></sec><sec id="jdi12498-sec-0010"><title>Diagnostic criteria</title><p>The glycemic thresholds for the diagnosis of diabetes and impaired glucose regulation were based on the 1999 WHO criteria. The diagnostic criteria and subgroups are described in Table<xref rid="jdi12498-tbl-0001" ref-type="table-wrap">1</xref>.</p><table-wrap id="jdi12498-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Diagnostic criteria and subgroups of prediabetes and diabetes</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Diagnosis</th><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Criteria</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Normal glucose tolerance</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">FPG &#x0003c; 6.1 mmol/L, and 2 h&#x02010;PPG &#x0003c; 7.8 mmol/L</td></tr><tr><td align="left" rowspan="3" colspan="1">Prediabetes</td><td align="left" rowspan="1" colspan="1">Isolated impaired fasting glucose</td><td align="left" rowspan="1" colspan="1">6.1 mmol/L &#x02264; FPG &#x0003c; 7.0 mmol/L, and 2 h&#x02010;PPG &#x0003c; 7.8 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Isolated impaired glucose tolerance</td><td align="left" rowspan="1" colspan="1">FPG &#x0003c; 6.1 mmol/L, and 7.8 mmol/L &#x02264; 2 h&#x02010;PPG &#x0003c; 11.1 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Combined impaired fasting glucose and impaired glucose tolerance</td><td align="left" rowspan="1" colspan="1">6.1 mmol/L &#x02264; FPG &#x0003c; 7.0 mmol/L, and 7.8 mmol/L &#x02264; 2 h&#x02010;PPG &#x0003c; 11.1 mmol/L</td></tr><tr><td align="left" rowspan="3" colspan="1">Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">DM diagnosed depending merely on FPG (DM1)</td><td align="left" rowspan="1" colspan="1">FPG &#x02265; 7.0 mmol/L, and 2 h&#x02010;PPG &#x0003c; 11.1 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">DM diagnosed depending merely on 2 h&#x02010;PPG (DM2)</td><td align="left" rowspan="1" colspan="1">FPG &#x0003c; 7.0 mmol/L, and 2 h&#x02010;PPG &#x02265; 11.1 mmol/L</td></tr><tr><td align="left" rowspan="1" colspan="1">Both levels of FPG and 2 h&#x02010;PPG reach DM criteria (DM3)</td><td align="left" rowspan="1" colspan="1">FPG &#x02265; 7.0 mmol/L, and 2 h&#x02010;PPG &#x02265; 11.1 mmol/L</td></tr></tbody></table><table-wrap-foot><fn id="jdi12498-note-0001"><p>2 h&#x02010;PPG, 2 h postload plasma glucose; DM, diabetes mellitus; DM1, type 1 diabetes mellitus; DM2, type 2 diabetes mellitus; DM3, type 3 diabetes mellitus; FPG, fasting plasma glucose.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="jdi12498-sec-0011"><title>Statistical analysis</title><p>Statistical analyses were carried out using <sc>spss</sc> (version 18.0; IBM Corporation, Armonk, NY, USA) and open&#x02010;source R (version 2.15.1; Auckland University, Auckland, New Zealand) software. Data were plotted with Graph Pad Prism software (version 5.0; GraphPad Software; La Jolla, CA, USA). Continuous variables are presented as the mean &#x000b1; standard deviation; the <italic>t</italic>&#x02010;test was used for comparison between two groups, and the <italic>F</italic>&#x02010;test (analysis of variance) was used for comparison of groups of more than two. Categorical variables were expressed as percentages. The &#x003c7;<sup>2</sup>&#x02010;test was used for comparison between multiple groups. A <italic>P</italic>&#x02010;value &#x0003c;0.05 was considered statistically significant.</p><p>The receiver operating characteristic (ROC) curves were achieved using open&#x02010;source R software (version 2.15.1; Auckland University) and the p&#x02010;ROC package<xref rid="jdi12498-bib-0023" ref-type="ref">23</xref>. In the present study, two ROC curves were plotted: one for people diagnosed with diabetes, and the other for people diagnosed with prediabetes by FPG, 2 h&#x02010;PPG and HbA1c, respectively. In general, an area under the curve (AUC) &#x0003e;0.9 indicates a high diagnostic value, 0.7 &#x0003c; AUC &#x02264; 0.9 indicates a moderate diagnostic value, and 0.5 &#x0003c; AUC &#x02264; 0.7 indicates a low diagnostic value. Optimal cut&#x02010;off values were obtained based on the highest Youden index across various cut&#x02010;off points as reviewed previously<xref rid="jdi12498-bib-0024" ref-type="ref">24</xref>.</p></sec></sec><sec id="jdi12498-sec-0012"><title>Results</title><p>The final analysis included 7,611 participants (2,435 men and 5,176 women). Table<xref rid="jdi12498-tbl-0002" ref-type="table-wrap"> 2</xref> shows the clinical characteristics of the participants. No differences were detected in 2 h&#x02010;PPG and HbA1c levels between men and women. However, the levels of FPG, triglycerides, age, systolic/diastolic pressure, body mass index and waist&#x02010;to&#x02010;hip ratio were considerably higher in men compared with women; whereas the levels of high&#x02010;density lipoprotein cholesterol, low&#x02010;density lipoprotein cholesterol and total cholesterol were significantly higher in women compared with men.</p><table-wrap id="jdi12498-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Clinical characteristics of the participants</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th><th align="char" char="&#x000b1;" valign="top" rowspan="1" colspan="1">Total</th><th align="center" valign="top" rowspan="1" colspan="1">Men</th><th align="char" char="&#x000b1;" valign="top" rowspan="1" colspan="1">Women</th><th align="center" valign="top" rowspan="1" colspan="1">
<italic>P</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic>n</italic>
</td><td align="char" rowspan="1" colspan="1">7,611</td><td align="center" rowspan="1" colspan="1">2,435</td><td align="center" rowspan="1" colspan="1">5,176</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">57.77 &#x000b1; 9.64</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">59.15 &#x000b1; 10.08</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">57.13 &#x000b1; 9.36</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">140.03 &#x000b1; 21.79</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">143.06 &#x000b1; 21.00</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">138.61 &#x000b1; 22.00</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">80.33 &#x000b1; 11.89</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">83.35 &#x000b1; 11.62</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">78.92 &#x000b1; 11.75</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">24.89 &#x000b1; 3.72</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">25.29 &#x000b1; 3.82</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">24.71 &#x000b1; 3.66</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist&#x02010;tp&#x02010;hip ratio</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.859 &#x000b1; 0.073</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.882 &#x000b1; 0.077</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">0.849 &#x000b1; 0.069</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">FPG (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.76 &#x000b1; 1.16</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.90 &#x000b1; 1.30</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.70 &#x000b1; 1.09</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">2 h&#x02010;PPG (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7.67 &#x000b1; 3.11</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7.66 &#x000b1; 3.35</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">7.67 &#x000b1; 2.99</td><td align="char" char="." rowspan="1" colspan="1">0.879</td></tr><tr><td align="left" rowspan="1" colspan="1">HbA1c (% mmol/mol)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.87 &#x000b1; 0.74</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.85 &#x000b1; 0.77</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.88 &#x000b1; 0.72</td><td align="char" char="." rowspan="1" colspan="1">0.067</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL&#x02010;C (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.31 &#x000b1; 0.30</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.23 &#x000b1; 0.29</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.35 &#x000b1; 0.29</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL&#x02010;C (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.93 &#x000b1; 0.75</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.85 &#x000b1; 0.74</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">2.97 &#x000b1; 0.76</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">CHOL (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.14 &#x000b1; 0.94</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">4.97 &#x000b1; 0.91</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">5.21 &#x000b1; 0.95</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">TG (mmol/L)</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.74 &#x000b1; 1.27</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.85 &#x000b1; 1.53</td><td align="char" char="&#x000b1;" rowspan="1" colspan="1">1.69 &#x000b1; 1.13</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal glucose tolerance</td><td align="center" rowspan="1" colspan="1">4,407 (57.90%)</td><td align="center" rowspan="1" colspan="1">1,345 (55.23%)</td><td align="center" rowspan="1" colspan="1">3,062 (59.16%)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Prediabetes</td><td align="center" rowspan="1" colspan="1">2,237 (29.39%)</td><td align="center" rowspan="1" colspan="1">728 (29.90%)</td><td align="center" rowspan="1" colspan="1">1,509 (29.15%)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">362 (14.87%)</td><td align="center" rowspan="1" colspan="1">605 (11.69%)</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="jdi12498-note-0002"><p>2 h&#x02010;PPG, 2 h postload plasma glucose; CHOL, cholesterol; DM, diabetes mellitus; DM1, type 1 diabetes mellitus; DM2, type 2 diabetes mellitus; DM3, type 3 diabetes mellitus; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin; HDL&#x02010;C, high&#x02010;density lipoprotein cholesterol; LDL&#x02010;C, low&#x02010;density lipoprotein cholesterol; TG, triglyceride.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>In the present study, we identified a total of 4,407 (58%) participants with normal glucose tolerance, 2,237 (29%) with prediabetes and 967 (13%) with diabetes (Table<xref rid="jdi12498-tbl-0002" ref-type="table-wrap"> 2</xref>). We found that the prevalence of diabetes and prediabetes increased with age (Figure <xref rid="jdi12498-fig-0001" ref-type="fig">1</xref>a); and the prevalence of diabetes in men was higher than that in women (Figure <xref rid="jdi12498-fig-0001" ref-type="fig">1</xref>b). Furthermore, based on the subgroups in Table<xref rid="jdi12498-tbl-0001" ref-type="table-wrap"> 1</xref>, the prevalence of isolated impaired fasting glucose (iIFG), isolated impaired glucose tolerance (iIGT), and the combination of iIFG and iIGT was 7.15%, 15.24%, and 7.52%, respectively, in men, and the prevalence in women was 4.66%, 18.88% and 5.62% (Figure <xref rid="jdi12498-fig-0002" ref-type="fig">2</xref>a). Meanwhile, the prevalence of type 1 diabetes mellitus, type 2 diabetes mellitus and type 3 diabetes mellitus was 2.51%, 5.75% and 6.61% in the male population, and the prevalence was 1.78%, 5.24% and 4.68% in the female population, respectively. Together, these data suggested that among all types of dysglycemia, the proportion of respondents with abnormal 2 h&#x02010;PPG levels was relatively high.</p><fig fig-type="Figure" xml:lang="en" id="jdi12498-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>(a) The prevalence of undiagnosed diabetes (<styled-content style="fixed-case">DM</styled-content>) and prediabetes (pre<styled-content style="fixed-case">DM</styled-content>) by age. (b) The prevalence of undiagnosed diabetes and prediabetes among the male and female population.</p></caption><graphic id="nlm-graphic-3" xlink:href="JDI-7-695-g001"/></fig><fig fig-type="Figure" xml:lang="en" id="jdi12498-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>(a) The prevalence of three kinds of impaired glucose regulation in the male and female population. (b) The prevalence of three types of diabetes in the male and female population. <styled-content style="fixed-case">DM</styled-content>1, type 1 diabetes mellitus; <styled-content style="fixed-case">DM</styled-content>2, type 2 diabetes mellitus; <styled-content style="fixed-case">DM</styled-content>3, type 3 diabetes mellitus; <styled-content style="fixed-case">IFG</styled-content>, impaired fasting glucose; <styled-content style="fixed-case">iIFG</styled-content>, isolated impaired fasting glucose; <styled-content style="fixed-case">iIGT</styled-content>, isolated impaired glucose tolerance.</p></caption><graphic id="nlm-graphic-5" xlink:href="JDI-7-695-g002"/></fig><p>In contrast, the proportions of isolated postload hyperglycemia were higher than that of isolated fasting hyperglycemia in diabetic and prediabetic participants among all adult age groups, regardless of sex (Figure<xref rid="jdi12498-fig-0003" ref-type="fig"> 3</xref>). It was found that 31.2&#x02013;58.8% of diabetic patients suffer from isolated postload hyperglycemia, and that 41.1&#x02013;68.7% of prediabetic patients suffer from isolated postload hyperglycemia.</p><fig fig-type="Figure" xml:lang="en" id="jdi12498-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>(a) The proportion of three kinds of impaired glucose regulation in the male population in different age groups. (b) The proportion of three kinds of impaired glucose regulation in the female population in different age groups. (c) The proportion of three types of diabetes in the male population in different age groups. (d) The proportion of three types of diabetes in the male population in different age groups. <styled-content style="fixed-case">DM</styled-content>1, type 1 diabetes mellitus; <styled-content style="fixed-case">DM</styled-content>2, type 2 diabetes mellitus; <styled-content style="fixed-case">DM</styled-content>3, type 3 diabetes mellitus; <styled-content style="fixed-case">IFG</styled-content>, impaired fasting glucose; <styled-content style="fixed-case">iIFG</styled-content>, isolated impaired fasting glucose; <styled-content style="fixed-case">iIGT</styled-content>, isolated impaired glucose tolerance.</p></caption><graphic id="nlm-graphic-7" xlink:href="JDI-7-695-g003"/></fig><p>As shown in Figure<xref rid="jdi12498-fig-0004" ref-type="fig"> 4</xref>, the ROC curves represent the diagnostic ability of FPG, 2 h&#x02010;PPG and HbA1c for diabetes (Figure <xref rid="jdi12498-fig-0004" ref-type="fig">4</xref>a) and prediabetes (Figure <xref rid="jdi12498-fig-0004" ref-type="fig">4</xref>b), respectively. For diabetes, the AUC was 0.8368 (95% confidence interval [CI] 0.828&#x02013;0.883) for FPG, 0.933 (95% CI 0.9198&#x02013;0.9462) for 2 h&#x02010;PPG and 0.8064 (95% CI 0.7886&#x02013;0.8241) for HbA1c. For prediabetes, the AUC was 0.8022 (95% CI 0.7905&#x02013;0.8140) for FPG, 0.9282 (95% CI 0.9189&#x02013;0.9356) for 2 h&#x02010;PPG and 0.6895 (95% CI 0.6759&#x02013;0.7032) for HbA1c. Our data clearly showed that the 2 h&#x02010;PPG AUC values were the best indicators for both diabetes and prediabetes identifications.</p><fig fig-type="Figure" xml:lang="en" id="jdi12498-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Receiver operating characteristic curves of fasting plasma glucose (<styled-content style="fixed-case">FPG</styled-content>), 2&#x02010;h postload plasma glucose (2 h&#x02010;<styled-content style="fixed-case">PPG</styled-content>) and glycosylated hemoglobin (HbA1c) in screening (a) undiagnosed diabetes and (b) prediabetes from all participants. For diabetes, the area under the curve (<styled-content style="fixed-case">AUC</styled-content>) of <styled-content style="fixed-case">FPG</styled-content> was 0.8368 (95% confidence interval [<styled-content style="fixed-case">CI</styled-content>] 0.828&#x02013;0.883), the <styled-content style="fixed-case">AUC</styled-content> of 2 h&#x02010;<styled-content style="fixed-case">PPG</styled-content> was 0.933 (95% <styled-content style="fixed-case">CI</styled-content> 0.9198&#x02013;0.9462), which was the largest, and the <styled-content style="fixed-case">AUC</styled-content> of HbA1c was 0.8064 (95% <styled-content style="fixed-case">CI</styled-content> 0.7886&#x02013;0.8241). For prediabetes, the <styled-content style="fixed-case">AUC</styled-content> of <styled-content style="fixed-case">FPG</styled-content> was 0.8022 (95% <styled-content style="fixed-case">CI</styled-content> 0.7905&#x02013;0.8140), the <styled-content style="fixed-case">AUC</styled-content> of 2 h&#x02010;<styled-content style="fixed-case">PPG</styled-content> was 0.9282 (95% <styled-content style="fixed-case">CI</styled-content> 0.9189&#x02013;0.9356), which was the largest, and the <styled-content style="fixed-case">AUC</styled-content> of HbA1c was 0.6895 (95% <styled-content style="fixed-case">CI</styled-content> 0.6759&#x02013;0.7032).</p></caption><graphic id="nlm-graphic-9" xlink:href="JDI-7-695-g004"/></fig><p>In the present study, we also explored the optimal cut&#x02010;off for HbA1c in screening diabetes and prediabetes. We investigated the sensitivity, specificity, Youden index, positive predictive value, and negative predictive value for identifying diabetes and prediabetes with different HbA1c thresholds. As shown in Supplemental Table<xref rid="jdi12498-tbl-0001" ref-type="table-wrap"> 1</xref>, when the thresholds increased, the sensitivity decreased and the specificity increased. An HbA1c threshold of 6.3% showed a moderate sensitivity of 66.97% (95% CI 64.01&#x02013;69.93%) and a specificity of 81.02% (95% CI 79.39&#x02013;82.65%) for detecting diabetes; however, a high Youden index was achieved (0.4799, 95% CI 0.4461&#x02013;0.5137). In contrast, an HbA1c threshold of 5.8% showed a moderate sensitivity of 64.59% (95% CI 62.61&#x02013;66.57%) and a specificity of 64.27% (95% CI 62.86&#x02013;65.68%) for detecting prediabetes, whereas a high Youden index (0.2886, 95% CI 0.2642&#x02013;0.313) was obtained (Supplemental Table<xref rid="jdi12498-tbl-0002" ref-type="table-wrap"> 2</xref>). According to a previous study<xref rid="jdi12498-bib-0024" ref-type="ref">24</xref>, we considered HbA1c thresholds of 6.3% (45 mmol/mol) and 5.8% (40 mmol/mol) as optimal cut&#x02010;off values to screen diabetes and prediabetes, respectively.</p></sec><sec id="jdi12498-sec-0013"><title>Discussion</title><p>FPG, 2 h&#x02010;PPG, and HbA1c measurements are the most common methods to screen or diagnose diabetes and prediabetes. Many researchers believe that the 2 h&#x02010;PPG test is time&#x02010;consuming and limited by poor reproducibility; therefore, it is not a popular glucose screening method. However, a previous study by Qiao <italic>et al</italic>. has shown that in Chinese women over the age of 40 years, the 2 h&#x02010;PPG level is significantly increased<xref rid="jdi12498-bib-0025" ref-type="ref">25</xref>. Another study by Louis <italic>et al</italic>.<xref rid="jdi12498-bib-0026" ref-type="ref">26</xref> has suggested that the elevated 2 h&#x02010;PPG level is mainly manifested in the early stages of type 2 diabetes. Some studies have shown that 2 h&#x02010;PPG, similar to HbA1c, is also an important predictor of risk for cardiovascular events and all&#x02010;cause mortality<xref rid="jdi12498-bib-0027" ref-type="ref">27</xref>. Therefore, regular monitoring of 2 h&#x02010;PPG is very critical in the early detection and prevention of type 2 diabetes and its chronic complications.</p><p>In the present study, we carried out three different measurements including FPG, 2 h&#x02010;PPG and HbA1c, and evaluated each method by statistical comparisons, in which the WHO 1999 standards were chosen as the gold standard. The cut&#x02010;off points for FPG and 2 h&#x02010;PPG in the diagnosis of diabetes and prediabetes using the WHO 1999 standards were recommended by both the 2010 and 2013 editions of the Chinese Guidelines for T2DM<xref rid="jdi12498-bib-0015" ref-type="ref">15</xref>, <xref rid="jdi12498-bib-0028" ref-type="ref">28</xref>, which showed cost&#x02010;effectiveness in the prevention and detection of type 2 diabetes in China. We compared the area under the ROC curve and found that 2 h&#x02010;PPG had the highest AUC in the screening of diabetes, followed by FPG and HbA1c. It is worth noting that our AUC value for HbA1c was 0.8064 (95% CI 0.7886&#x02013;0.8241), which is comparable with the previously reported value of 0.856 (95% CI 0.828&#x02013;0.883) for people aged older than 20 years<xref rid="jdi12498-bib-0029" ref-type="ref">29</xref>. In screening for prediabetes, 2 h&#x02010;PPG has an AUC value &#x0003e;0.9, suggesting a high diagnostic value, followed by FPG and HbA1c with values between 0.7&#x02013;0.9 and &#x0003c;0.7, respectively. The AUC of HbA1c was also similar to the previously reported values of 0.69 (European Caucasians) and 0.72 (South Asians) for people aged 40&#x02013;75 years in a multi&#x02010;ethnic cohort study in Great Britain<xref rid="jdi12498-bib-0030" ref-type="ref">30</xref>. In summary, 2 h&#x02010;PPG is the best method to screen for diabetes and prediabetes.</p><p>In the present study, we found that the proportion of participants with abnormal 2 h&#x02010;PPG levels was relatively high. If we did not carry out the 2 h&#x02010;PPG measurement, we would miss 23% of iIGT patients and 3% of diabetes patients in those with normal fasting blood glucose levels; and we would miss 43% of iIGT patients and 19% of diabetes patients in those with iIFG. Thus, the sensitivity of the 2 h&#x02010;PPG measurement in screening diabetes and prediabetes was higher than that of the FPG measurement. Although the Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe study<xref rid="jdi12498-bib-0025" ref-type="ref">25</xref> reported that the increased prevalence of undiagnosed diabetes and prediabetes was mainly a result of the large increase of 2 h&#x02010;PPG rather than FPG in an elderly European population, which showed that the proportion of isolated postload hyperglycemia was higher than that of isolated fasting hyperglycemia among those aged older than 60 years, we found that, in the present study, this happened among all participants aged older than 40 years. Thus, we concluded that the adult Chinese population was more prone to suffering postload hyperglycemia than European adults, showing an ethnic difference. This observation further emphasizes the importance and necessity of measuring 2 h&#x02010;PPG levels in Chinese adults.</p><p>Our current study identified that many people in different age groups were newly diagnosed with diabetes and prediabetes, suggesting that the undiagnosed cases were possibly a result of the limitation of the detection methods. Generally, men have a higher prevalence of diabetes and prediabetes than women, which might be associated with higher caloric intake, and exposure to smoking, alcohol, stress and other risk factors<xref rid="jdi12498-bib-0004" ref-type="ref">4</xref>, <xref rid="jdi12498-bib-0031" ref-type="ref">31</xref>. We also found that people with dysglycemia had a higher age distribution, body mass index, waist circumference, waist&#x02010;to&#x02010;hip circumference, blood pressure and family history of diabetes when compared with people with normal glucose levels (Supplemental Table 3). This observation is in line with previous studies<xref rid="jdi12498-bib-0004" ref-type="ref">4</xref>, <xref rid="jdi12498-bib-0017" ref-type="ref">17</xref>, <xref rid="jdi12498-bib-0032" ref-type="ref">32</xref>, <xref rid="jdi12498-bib-0033" ref-type="ref">33</xref>. Therefore, elderly people with a family history of diabetes, obesity, and hypertension should pay more attention to 2 h&#x02010;PPG screening to get an early diagnosis and interventions to prevent diabetes.</p><p>So far, there are some controversies regarding the cut&#x02010;off points of HbA1c for the diagnosis of diabetes and prediabetes. Both the ADA<xref rid="jdi12498-bib-0012" ref-type="ref">12</xref> and WHO<xref rid="jdi12498-bib-0011" ref-type="ref">11</xref> guidelines recommended HbA1c &#x02265;6.5% as a diagnostic cut&#x02010;off point for diabetes; and the ADA recommended HbA1c between 5.7% and 6.4% for prediabetes. However, the WHO did not suggest a clear HbA1c cut&#x02010;off value for prediabetes. Interestingly, a number of studies have shown that the correlation between HbA1c values and blood glucose levels shows a racial difference; therefore, the aforementioned recommended HbA1c cut&#x02010;off points by the ADA and WHO might not be optimal for the Chinese population<xref rid="jdi12498-bib-0016" ref-type="ref">16</xref>, <xref rid="jdi12498-bib-0030" ref-type="ref">30</xref>. In the present study, we evaluated different HbA1c cut&#x02010;off points in screening diabetes and prediabetes by examining the sensitivity, specificity, and Youden index. The present results suggested an optimal HbA1c cut&#x02010;off point of 6.3% in screening diabetes, consistent with a previous study<xref rid="jdi12498-bib-0029" ref-type="ref">29</xref>. We also proposed an ideal HbA1c cut&#x02010;off point of 5.8% in screening prediabetes. To the best of our knowledge, there are no reports on the HbA1c cut&#x02010;off point for the diagnosis of prediabetes using a large sample pool in China. The present study will greatly advance our understanding of the importance of the HbA1c cut&#x02010;off point, and increase the diagnosis of diabetes and prediabetes in a Chinese population. However, there are some limitations for its use in China. First of all, standardization of HbA1c has not been used widely in the laboratories of Chinese hospitals. Although the measurement of HbA1c is a stable method for screening diabetes and prediabetes, based on the results of the present study, HbA1c sensitivity is somewhat lower and the cost of HbA1c detection is somewhat higher, which might restrict its application in China.</p><p>In summary, the population of the present study from Changchun City, whether they had diabetes or prediabetes, had more abnormal 2 h&#x02010;PPG levels compared with FPG levels, which might indirectly reflect a decreased insulin secretion from pancreatic islet &#x003b2;&#x02010;cells and different diet compositions in the Chinese population. Islet &#x003b2;&#x02010;cell function, insulin resistance and glucose spectral characteristics in different ethnic populations require further study. Based on the present study, the 2 h&#x02010;PPG measurement is the best method to screen for diabetes and prediabetes.</p><p>We should mention that there are some limitations in the present study, such as an inadequate sample size for the male participants, which might result in a biased analysis. Additionally, because of the large overall sample size, we were unable to retest and confirm blood glucose abnormalities or investigate islet function and insulin resistance, which would be useful to assess the correlation between FPG, 2 h&#x02010;PPG or HbA1c and islet function or insulin resistance. The gold standard for determining ideal cut&#x02010;off points for screening methods of diabetes should be the incidence of diabetic retinopathy. Unfortunately, the present study, as a cross&#x02010;sectional study, only evaluated the sensitivity and specificity of the various methods in screening for diabetes and prediabetes, without evaluating the ability of each method to predict the chronic complications of diabetes, such as diabetic retinopathy. Future studies including a follow&#x02010;up survey and investigation will provide more valuable conclusions. Despite its limitations, our study provided reliable evidence for choosing a screening method for diabetes and prediabetes in Chinese or even an Asian population. Although there was a previous study by Bao <italic>et al</italic>.<xref rid="jdi12498-bib-0029" ref-type="ref">29</xref> reporting an HbA1c cut&#x02010;off point for screening diabetes, the present study for the first time showed an HbA1c cut&#x02010;off point for screening prediabetes in a general Chinese population by a large randomized observational study.</p><p>In conclusion, the 2&#x02010;h post&#x02010;load plasma glucose measurement is a necessary and cost&#x02010;effective method for screening diabetes and prediabetes in China. HbA1c &#x02265;6.3% (45 mmol/mol) and between 5.8% and 6.2% (40&#x02013;44 mmol/mol) are the optimal cut&#x02010;off values for the diagnosis of diabetes and prediabetes, respectively, in a Chinese population.</p></sec><sec id="jdi12498-sec-0015"><title>Disclosure</title><p>The authors declare no conflict of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data"><caption><p>
<bold>Table S1</bold> | Sensitivity, specificity, Youden index, positive and negative predictive value for detecting diabetes.</p><p>
<bold>Table S2</bold> | Sensitivity, specificity, Youden index, positive and negative predictive value for detecting prediabetes.</p><p>
<bold>Table S3</bold> | Additional clinical characteristics of the participants.</p></caption><media xlink:href="JDI-7-695-s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="jdi12498-sec-0014"><title>Acknowledgments</title><p>The authors thank the Shanghai Institute of Endocrinology and Metabolism for material and technical assistance. The authors also are grateful to the staff of the primary healthcare centers that supported this study in terms of material assistance and organizing participants.</p></ack><ref-list content-type="cited-references" id="jdi12498-bibl-0001"><title>References</title><ref id="jdi12498-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jdi12498-cit-0001">
<string-name>
<surname>Almdal</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Scharling</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>JS</given-names>
</string-name>, <italic>et al</italic>
<article-title>The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population&#x02010;based study of 13,000 men and women with 20 years of follow&#x02010;up</article-title>. <source>Arch Intern Med</source>
<year>2004</year>; <volume>164</volume>: <fpage>1422</fpage>&#x02013;<lpage>1426</lpage>.<pub-id pub-id-type="pmid">15249351</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jdi12498-cit-0002">
<string-name>
<surname>Barnett</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Ogston</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>McMurdo</surname>
<given-names>ME</given-names>
</string-name>, <italic>et al</italic>
<article-title>A 12&#x02010;year follow&#x02010;up study of all&#x02010;cause and cardiovascular mortality among 10 532 people newly diagnosed with type 2 diabetes in Tayside</article-title>. <source>Scotland. Diabet Med</source>
<year>2010</year>; <volume>27</volume>: <fpage>1124</fpage>&#x02013;<lpage>1129</lpage>.<pub-id pub-id-type="pmid">20854379</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jdi12498-cit-0003">
<string-name>
<surname>Chuang</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Hsu</surname>
<given-names>PF</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>SH</given-names>
</string-name>, <italic>et al</italic>
<article-title>Diabetes and 15&#x02010;year cardiovascular mortality in a Chinese population: differential impact of hypertension and metabolic syndrome</article-title>. <source>J Chin Med Assoc</source>
<year>2010</year>; <volume>73</volume>: <fpage>234</fpage>&#x02013;<lpage>240</lpage>.<pub-id pub-id-type="pmid">20685589</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jdi12498-cit-0004">
<string-name>
<surname>Yang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>J</given-names>
</string-name>, <italic>et al</italic>
<article-title>Prevalence of diabetes among men and women in China</article-title>. <source>N Engl J Med</source>
<year>2010</year>; <volume>362</volume>: <fpage>1090</fpage>&#x02013;<lpage>1101</lpage>.<pub-id pub-id-type="pmid">20335585</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0005"><label>5</label><mixed-citation publication-type="book" id="jdi12498-cit-0005">
<collab collab-type="authors">International Diabetes Federation</collab>
. <source>IDF Diabetes Atlas</source>, <edition>6th edn</edition>
<publisher-name>International Diabetes Federation</publisher-name>, <publisher-loc>Brussels, Belgium</publisher-loc>, <year>2013</year>.</mixed-citation></ref><ref id="jdi12498-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jdi12498-cit-0006">
<string-name>
<surname>Tabak</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Herder</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rathmann</surname>
<given-names>W</given-names>
</string-name>, <italic>et al</italic>
<article-title>Prediabetes: a high&#x02010;risk state for diabetes development</article-title>. <source>Lancet</source>
<year>2012</year>; <volume>379</volume>: <fpage>2279</fpage>&#x02013;<lpage>2290</lpage>.<pub-id pub-id-type="pmid">22683128</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jdi12498-cit-0007">
<string-name>
<surname>Gore</surname>
<given-names>MO</given-names>
</string-name>, <string-name>
<surname>McGuire</surname>
<given-names>DK</given-names>
</string-name>. <article-title>The 10&#x02010;year post&#x02010;trial follow&#x02010;up of the United Kingdom prospective diabetes Study (UKPDS): cardiovascular observations in context</article-title>. <source>Diab Vasc Dis Res</source>
<year>2009</year>; <volume>6</volume>: <fpage>53</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">19156632</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jdi12498-cit-0008">
<string-name>
<surname>Simmons</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jakes</surname>
<given-names>RW</given-names>
</string-name>, <italic>et al</italic>
<article-title>Effect of population screening for type 2 diabetes on mortality: long&#x02010;term follow&#x02010;up of the Ely cohort</article-title>. <source>Diabetologia</source>
<year>2011</year>; <volume>54</volume>: <fpage>312</fpage>&#x02013;<lpage>319</lpage>.<pub-id pub-id-type="pmid">20978739</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jdi12498-cit-0009">
<string-name>
<surname>Whiting</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Guariguata</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Weil</surname>
<given-names>C</given-names>
</string-name>, <italic>et al</italic>
<article-title>IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030</article-title>. <source>Diabetes Res Clin Pract</source>
<year>2011</year>; <volume>94</volume>: <fpage>311</fpage>&#x02013;<lpage>321</lpage>.<pub-id pub-id-type="pmid">22079683</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0010"><label>10</label><mixed-citation publication-type="book" id="jdi12498-cit-0010">
<collab collab-type="authors">World Health Organization</collab>
. <chapter-title>Definition, diagnosis and classification of diabetes mellitus and its complications</chapter-title>
<source>Report of World Health Organization Consultation</source>. Part 1: Diagnosis and classification of diabetes mellitus <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>1999</year>.</mixed-citation></ref><ref id="jdi12498-bib-0011"><label>11</label><mixed-citation publication-type="book" id="jdi12498-cit-0011">
<collab collab-type="authors">World Health Organization</collab>
. <source>Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>WTO</publisher-name>, <year>2011</year>.</mixed-citation></ref><ref id="jdi12498-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jdi12498-cit-0012">
<collab collab-type="authors">American Diabetes Association</collab>
. <article-title>Standards of medical care in diabetes&#x02014;2010</article-title>. <source>Diabetes Care</source>
<year>2011</year>; <volume>33</volume>(<issue>Suppl 1</issue>): <fpage>S11</fpage>&#x02013;<lpage>S61</lpage>.</mixed-citation></ref><ref id="jdi12498-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jdi12498-cit-0013">
<string-name>
<surname>Avogaro</surname>
<given-names>A</given-names>
</string-name>. <article-title>Postprandial glucose: marker or risk factor?</article-title>
<source>Diabetes Care</source>
<year>2011</year>; <volume>34</volume>: <fpage>2333</fpage>&#x02013;<lpage>2335</lpage>.<pub-id pub-id-type="pmid">21949226</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jdi12498-cit-0014">
<string-name>
<surname>Balkau</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Eschwege</surname>
<given-names>E</given-names>
</string-name>. <article-title>Epidemiological data on postprandial glycaemia</article-title>. <source>Diabetes Metab</source>
<year>2006</year>; <volume>32</volume>: <fpage>2S5</fpage>&#x02013;<lpage>2S9</lpage>.<pub-id pub-id-type="pmid">17375400</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jdi12498-cit-0015">
<collab collab-type="authors">Chinese Diabetes Society</collab>
. <article-title>China guideline for type 2 diabetes</article-title>. <source>Chin J Diabetes Mellitus</source>
<year>2010</year>; <volume>2</volume>(<issue>Suppl 2</issue>): <fpage>6</fpage>&#x02013;<lpage>56</lpage>.</mixed-citation></ref><ref id="jdi12498-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jdi12498-cit-0016">
<string-name>
<surname>Venkataraman</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Thai</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians Malays and Chinese</article-title>. <source>Diabet Med</source>
<year>2012</year>; <volume>29</volume>: <fpage>911</fpage>&#x02013;<lpage>917</lpage>.<pub-id pub-id-type="pmid">22283416</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jdi12498-cit-0017">
<string-name>
<surname>Zhou</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Pang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>W</given-names>
</string-name>, <italic>et al</italic>
<article-title>Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre&#x02010;diabetes defined by an oral glucose tolerance test in Qingdao</article-title>. <source>China. Diabetes Care</source>
<year>2010</year>; <volume>33</volume>: <fpage>545</fpage>&#x02013;<lpage>550</lpage>.<pub-id pub-id-type="pmid">20007941</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jdi12498-cit-0018">
<string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>T</given-names>
</string-name>, <italic>et al</italic>
<article-title>The relationship between insulin&#x02010;sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study</article-title>. <source>Int J Cardiol</source>
<year>2014</year>; <volume>172</volume>: <fpage>388</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">24502884</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jdi12498-cit-0019">
<string-name>
<surname>Bi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <italic>et al</italic>
<article-title>Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study</article-title>. <source>J Diabetes</source>
<year>2014</year>; <volume>6</volume>: <fpage>147</fpage>&#x02013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">24237858</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jdi12498-cit-0020">
<string-name>
<surname>Ning</surname>
<given-names>G</given-names>
</string-name>. <article-title>Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study</article-title>. <source>J Diabetes</source>
<year>2012</year>; <volume>4</volume>: <fpage>172</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">22221801</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jdi12498-cit-0021">
<string-name>
<surname>Tai</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>R</given-names>
</string-name>, <italic>et al</italic>
<article-title>Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian&#x02010;Indian men</article-title>. <source>Diabetologia</source>
<year>2010</year>; <volume>53</volume>: <fpage>757</fpage>&#x02013;<lpage>767</lpage>.<pub-id pub-id-type="pmid">20076942</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jdi12498-cit-0022">
<string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>Y</given-names>
</string-name>, <italic>et al</italic>
<article-title>Association of previous schistosome infection with diabetes and metabolic syndrome: a cross&#x02010;sectional study in rural China</article-title>. <source>J Clin Endocrinol Metab</source>
<year>2013</year>; <volume>98</volume>: <fpage>E283</fpage>&#x02013;<lpage>E287</lpage>.<pub-id pub-id-type="pmid">23275524</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jdi12498-cit-0023">
<string-name>
<surname>Robin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Turck</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hainard</surname>
<given-names>A</given-names>
</string-name>, <italic>et al</italic>
<article-title>pROC: an open&#x02010;source package for R and S+ to analyze and compare ROC curves</article-title>. <source>BMC Bioinformatics</source>
<year>2011</year>; <volume>12</volume>: <fpage>77</fpage>.<pub-id pub-id-type="pmid">21414208</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jdi12498-cit-0024">
<string-name>
<surname>Hajian&#x02010;Tilaki</surname>
<given-names>K</given-names>
</string-name>. <article-title>Receiver operating characteristic (roc) curve analysis for medical diagnostic test evaluation</article-title>. <source>Caspian J Intern Med</source>
<year>2013</year>; <volume>4</volume>: <fpage>627</fpage>&#x02013;<lpage>635</lpage>.<pub-id pub-id-type="pmid">24009950</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jdi12498-cit-0025">
<string-name>
<surname>Qiao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tuomilehto</surname>
<given-names>J</given-names>
</string-name>, <italic>et al</italic>
<article-title>Age&#x02010; and sex&#x02010;specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts</article-title>. <source>Diabetes Care</source>
<year>2003</year>; <volume>26</volume>: <fpage>1770</fpage>&#x02013;<lpage>1780</lpage>.<pub-id pub-id-type="pmid">12766108</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jdi12498-cit-0026">
<string-name>
<surname>Monnier</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Colette</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Dunseath</surname>
<given-names>GJ</given-names>
</string-name>, <italic>et al</italic>
<article-title>The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes</article-title>. <source>Diabetes Care</source>
<year>2007</year>; <volume>30</volume>: <fpage>263</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">17259492</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jdi12498-cit-0027">
<string-name>
<surname>Cavalot</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Pagliarino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Valle</surname>
<given-names>M</given-names>
</string-name>, <italic>et al</italic>
<article-title>Postprandial blood glucose predicts cardiovascular events and all&#x02010;cause mortality in type 2 diabetes in a 14&#x02010;year follow&#x02010;up: lessons from the San Luigi Gonzaga diabetes Study</article-title>. <source>Diabetes Care</source>
<year>2011</year>; <volume>34</volume>: <fpage>2237</fpage>&#x02013;<lpage>2243</lpage>.<pub-id pub-id-type="pmid">21949221</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jdi12498-cit-0028">
<collab collab-type="authors">Chinese Diabetes Society</collab>
. <article-title>China guideline for type 2 diabetes</article-title>. <source>Chinese Journal of Diabetes Mellitus</source>; <year>2014</year>; <volume>6</volume>: <fpage>447</fpage>&#x02013;<lpage>498</lpage>.</mixed-citation></ref><ref id="jdi12498-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jdi12498-cit-0029">
<string-name>
<surname>Bao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>H</given-names>
</string-name>, <italic>et al</italic>
<article-title>Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey</article-title>. <source>BMJ</source>
<year>2010</year>; <volume>340</volume>: <fpage>c2249</fpage>.<pub-id pub-id-type="pmid">20478961</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jdi12498-cit-0030">
<string-name>
<surname>Mostafa</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Khunti</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Srinivasan</surname>
<given-names>BT</given-names>
</string-name>, <italic>et al</italic>
<article-title>The potential impact and optimal cut&#x02010;points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi&#x02010;ethnic cohort</article-title>. <source>Diabetes Res Clin Pract</source>
<year>2010</year>; <volume>90</volume>: <fpage>100</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">20633944</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jdi12498-cit-0031">
<string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <italic>et al</italic>
<article-title>Prevalence of diabetes and impaired fasting glucose in Chinese adults, China National Nutrition and Health Survey, 2002</article-title>. <source>Prev Chronic Dis</source>
<year>2011</year>; <volume>8</volume>: <fpage>A13</fpage>.<pub-id pub-id-type="pmid">21159225</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jdi12498-cit-0032">
<string-name>
<surname>Weber</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Oza&#x02010;Frank</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Staimez</surname>
<given-names>LR</given-names>
</string-name>, <italic>et al</italic>
<article-title>Type 2 diabetes in Asians: prevalence, risk factors, and effectiveness of behavioral intervention at individual and population levels</article-title>. <source>Annu Rev Nutr</source>
<year>2012</year>; <volume>32</volume>: <fpage>417</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">22524185</pub-id></mixed-citation></ref><ref id="jdi12498-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jdi12498-cit-0033">
<string-name>
<surname>Zhang</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>WJ</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>GN</given-names>
</string-name>, <italic>et al</italic>
<article-title>Diabetes and pre&#x02010;diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population</article-title>. <source>PLoS ONE</source>
<year>2012</year>; <volume>7</volume>: <fpage>e37260</fpage>.<pub-id pub-id-type="pmid">22615957</pub-id></mixed-citation></ref></ref-list></back></article>